87 related articles for article (PubMed ID: 3332014)
1. Detection of genes with potential of suppressing transforming activity of the v-Ki-ras oncogene.
Noda M; Ikawa Y
Princess Takamatsu Symp; 1986; 17():261-7. PubMed ID: 3332014
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M
Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339
[TBL] [Abstract][Full Text] [Related]
3. Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes.
Noda M; Kitayama H; Matsuzaki T; Sugimoto Y; Okayama H; Bassin RH; Ikawa Y
Proc Natl Acad Sci U S A; 1989 Jan; 86(1):162-6. PubMed ID: 2463620
[TBL] [Abstract][Full Text] [Related]
4. Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes.
Sklar MD
Cancer Res; 1988 Feb; 48(4):793-7. PubMed ID: 3276398
[TBL] [Abstract][Full Text] [Related]
5. Human bronchial epithelial cells neoplastically transformed by v-Ki-ras: altered response to inducers of terminal squamous differentiation.
Reddel RR; Ke Y; Kaighn ME; Malan-Shibley L; Lechner JF; Rhim JS; Harris CC
Oncogene Res; 1988; 3(4):401-8. PubMed ID: 3067190
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the human Harvey-ras oncogene expression by DNA methylation.
Borrello MG; Pierotti MA; Donghi R; Bongarzone I; Cattadori MR; Traversari C; Mondellini P; Della Porta G
Oncogene Res; 1988; 2(2):197-203. PubMed ID: 2464152
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional profile of Ki-Ras-induced transformation of thyroid cells.
Visconti R; Federico A; Coppola V; Pentimalli F; Berlingieri MT; Pallante P; Kruhoffer M; Orntoft TF; Fusco A
Cancer Invest; 2007 Jun; 25(4):256-66. PubMed ID: 17612936
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation of an infinite life span human fibroblast cell strain by transfection with v-Ki-ras.
Fry DG; Milam LD; Dillberger JE; Maher VM; McCormick JJ
Oncogene; 1990 Sep; 5(9):1415-8. PubMed ID: 2216465
[TBL] [Abstract][Full Text] [Related]
9. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
Salomon DS; Zwiebel JA; Noda M; Bassin RH
J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of MSX-2 homeoprotein in v-ras-induced transformation.
Takahashi C; Akiyama N; Kitayama H; Takai S; Noda M
Leukemia; 1997 Apr; 11 Suppl 3():340-3. PubMed ID: 9209384
[TBL] [Abstract][Full Text] [Related]
11. Amplification and activation of c-Ki-ras oncogene in cell line developed from human pancreas explants.
Maheshwari KK; Parsa I
Biochem Int; 1991 Sep; 25(2):233-40. PubMed ID: 1789790
[TBL] [Abstract][Full Text] [Related]
12. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
Su ZZ; Austin VN; Zimmer SG; Fisher PB
Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
[TBL] [Abstract][Full Text] [Related]
13. A role for Ras in v-Crk transformation.
Greulich H; Hanafusa H
Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
[TBL] [Abstract][Full Text] [Related]
14. The normal human H-ras1 gene can act as an onco-suppressor.
Spandidos A; Wilkie NM
Br J Cancer Suppl; 1988 Dec; 9():67-71. PubMed ID: 3076068
[TBL] [Abstract][Full Text] [Related]
15. Differentiation can convey resistance to transformation by activated ras oncogene.
Tzen CY; Maercklein PB; Scott RE
Anticancer Res; 1990; 10(5A):1329-34. PubMed ID: 2241110
[TBL] [Abstract][Full Text] [Related]
16. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
Radinsky R; Kraemer PM; Proffitt MR; Culp LA
Cancer Res; 1988 Sep; 48(17):4941-53. PubMed ID: 3409227
[TBL] [Abstract][Full Text] [Related]
17. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
Xin H; Geng Y; Pramanik R; Choubey D
J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
[TBL] [Abstract][Full Text] [Related]
18. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
19. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
[TBL] [Abstract][Full Text] [Related]
20. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
